The Pacer US Cash Cows 100 ETF (COWZ) is an exchange-traded fund that tracks the Pacer US Cash Cows 100 Index, a rules-based portfolio of roughly 100 large- and mid-cap U.S. companies screened and weighted for high free cash flow yield (cash a business generates after capital spending, relative to its market value). Because COWZ is an ETF rather than a single stock, it carries no stand-alone analyst price target of its own. The $81 objective explored here is derived from public market data on the fund's underlying holdings, not from an official ETF consensus.
Because COWZ is an ETF, there is no single Wall Street analyst issuing a price target on the fund itself. Instead, financial data platforms aggregate the price targets that analysts assign to each of the fund's roughly 100 holdings and weight them by position size. According to TipRanks, this holdings-weighted calculation produced an average 12-month price target of approximately $80.85 across the fund's constituents, with a low forecast near $62.27 and a high forecast near $99.28. Rounded to a cleaner, reader-friendly figure, that average becomes the $81 objective examined here.
It is important to distinguish this from a published consensus on the ETF. The $81 level is best understood as a proxy: what the market's collective analyst expectations for COWZ's component stocks imply for the fund, rather than a forecast any single firm has made for COWZ. The same underlying data assigns the fund's holdings an aggregate "Moderate Buy" rating, built from a large majority of Buy ratings alongside a smaller number of Hold and Sell calls.
COWZ has traded recently in the high-$60s to low-$70s, just below its 52-week high of roughly $72.52, after rising from a 52-week low near $56.84. Using a reference price of about $70, moving to $81 implies an upside of approximately 15%, a substantial but not extreme move for a diversified equity fund over a 12-month horizon. The path would most plausibly run through its component stocks: if the large-cap "cash cow" names that dominate the portfolio continue to see analyst estimates and valuations firm, the fund's net asset value would be pulled higher. COWZ's broad sector exposure—led by technology, healthcare, and energy—means the route is more dependent on value-style equity performance and free-cash-flow generation than on any single company's results.
Several structural factors underpin the bullish case. First, the fund's methodology favors companies with high free cash flow yields, a quality screen that tends to surface financially resilient, capital-generating businesses. Its portfolio trades at a price-to-earnings ratio in the mid-teens and carries a weighted dividend yield around 2%, offering a value-oriented profile relative to more growth-heavy benchmarks. Notably, the fund holds no financial, utility, or real estate exposure, concentrating its risk in cash-generative sectors. Heavy positions in names such as Accenture (ACN), Gilead Sciences (GILD), Chevron (CVX), IBM (IBM), and Marathon Petroleum (MPC) link the fund's fortunes to resilient cash-flow businesses. If value stocks continue to participate in a broadening equity rally, and if energy and healthcare remain supported by earnings and demand, COWZ's components could collectively drift toward their aggregate targets.
The principal risks are equally concrete. COWZ has recorded meaningful net outflows over the past year—on the order of $3 billion according to fund-flow trackers—suggesting investors have been rotating away from value-oriented strategies even as the fund has climbed. A market environment favoring high-growth, low-yield technology leaders could leave the fund's cash-cow portfolio lagging. Energy exposure, while a potential tailwind, also introduces cyclicality and sensitivity to oil prices. Finally, because the $81 figure is a weighted average of holdings' targets with a wide range (roughly $62 to $99), it represents a midpoint of divergent views rather than a high-confidence level; any deterioration in the earnings outlook for large healthcare or energy constituents could compress the implied objective.
From a technical standpoint, COWZ has been consolidating near its 52-week high of about $72.52, which acts as the nearest significant resistance level. A decisive move above that high would remove the most immediate overhead supply, while $70 and $75 serve as notable psychological levels on the way toward $81. On the downside, the fund's prior consolidation zone in the mid-to-high $60s offers nearby support, with deeper support near $60 and the 52-week low around $56.84. The fund's beta of roughly 0.7 indicates lower volatility than the broader market, which can moderate both upside and downside moves.
Analyst price targets on individual stocks generally reflect a research horizon of about 12 months, and the holdings-weighted $81 figure inherits that convention, though individual firms may differ. Investors should monitor the fund's quarterly rebalancing and sector weightings, ongoing fund flows, and the earnings results and guidance of its largest holdings, particularly in technology, healthcare, and energy. Macroeconomic variables—interest-rate policy from the FOMC (Federal Open Market Committee), inflation readings, and oil prices—will also influence whether the value-style rotation that favors COWZ continues.
Tickeron's AI Daily Buy/Sell Signals apply artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on shifting market conditions, technical behavior, and AI-driven analysis. Rather than replacing an investor's judgment, the tool is designed to help traders discover opportunities, track existing positions, and identify changing trends more efficiently. Investors following COWZ can use such signals to complement their own research on fund flows, sector rotation, and valuation. Exploring the AI Daily Buy/Sell Signals can add a data-driven layer to the decision-making process.
The question of whether COWZ can reach $81 hinges on a proxy, not a direct forecast. The $81 level reflects the weighted average of analyst price targets on the fund's roughly 100 holdings—a figure with a wide $62-to-$99 range that underscores genuine disagreement. Achieving it would require a rise of about 15% from current levels, driven by continued strength in cash-generative value stocks across technology, healthcare, and energy. Supportive factors include the fund's free-cash-flow screen, mid-teens valuation, and dividend yield, while outflows, value-style cyclicality, and energy sensitivity present the main obstacles. Investors should treat $81 as a reference point derived from underlying holdings' expectations and monitor fund flows, sector rebalancing, and macroeconomic conditions rather than treating the level as a certainty.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, COWZ has been closely correlated with PY. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if COWZ jumps, then PY could also see price increases.
| Ticker / NAME | Correlation To COWZ | 1D Price Change % | ||
|---|---|---|---|---|
| COWZ | 100% | -0.53% | ||
| PY - COWZ | 93% Closely correlated | -0.31% | ||
| FNK - COWZ | 93% Closely correlated | -0.89% | ||
| XMVM - COWZ | 85% Closely correlated | -0.84% | ||
| VFVA - COWZ | 84% Closely correlated | -1.11% | ||
| VUSE - COWZ | 83% Closely correlated | -0.46% | ||
More | ||||